早期持续正压通气联合肺表面活性物质治疗早产儿肺透明膜病疗效评价

来源 :中国新生儿科杂志 | 被引量 : 0次 | 上传用户:fq8628
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
新生儿肺透明膜病(hyaline membrane d isease ofnewbron,NHMD)多见于早产儿,以生后不久出现进行性呼吸困难为特点,病理以肺泡壁至终末细支气管壁附有嗜伊红透明膜和肺不张为特征,其发病基础是肺表面活性物质(PS)缺乏,是早产儿死亡的重要原因之一。我院新生儿科与产科协作,采用 Neonatal hyaline membrane d isease of newbronch disease (NHMD) more common in premature children, shortly after birth, characterized by progressive dyspnea, the pathology of the alveolar wall to the end of the bronchial wall with eudesorvate transparent membrane and Atelectasis is characterized by the lack of pulmonary surfactant (PS), which is one of the important causes of death in premature infants. Neonatology in our hospital and obstetric collaboration, adoption
其他文献